[NMusers] Open Pharmacometrician position, Calvagone

[Emilie Henin]

*Pharmacometrician *

At Calvagone we are seeking an experienced pharmacometrician to join our
team as a consultant. The ideal candidate will have a strong background in
pharmacokinetics, pharmacodynamics, and statistical modeling, as well as
good understanding of the drug development process.



Who we are?

Calvagone is a consultancy company providing pharmacometric services to the
biopharmaceutical industry. We are a compact group of scientists with
diverse backgrounds including pharmacists, statisticians and software
engineers. If you join us, you will be able to work remotely full-time on
interesting and challenging pharmacometrics projects and will have the
opportunity to contribute first-hand to the development of our online
simulation platform www.e-campsis.com.



Your role:

·Provide pharmacometric support on a variety of projects at various
stages of development, including the hands-on development of population
pharmacokinetic and pharmacodynamic models and the simulation of clinical
trial data

·Scoping of potential projects and writing project proposals for
clients

·Collaborate with the client’s cross-functional teams, including
clinical development, regulatory affairs, and statistics

·Review and interpret clinical study reports and regulatory
documents

·Prepare reports, presentations, and manuscripts

·Stay up-to-date with the latest developments in pharmacometric
techniques and software

·Participate in the development of software tools (e.g. R-packages,
e-Campsis) or processes and procedures to improve internal workflows



Qualifications:

·A PhD or equivalent in pharmacometrics, pharmaceutical sciences,
statistics or a related field

·Hands-on experience with R

·Hands-on experience with NONMEM

·Excellent communication and problem-solving skills

·Ability to work independently or in a small team

·Home-office, based in Europe with good internet connection



If you are interested in this exciting opportunity, please submit your CV
and a motivation letter highlighting your relevant experience to
cont...@calvagone.com.




Emilie;

on behlf of Calvagone team

[NMusers] PAGE 2024: e-Campsis training

[Emilie Henin]

e-Campsis Workshop at PAGE 2024 in Rome

On Tuesday the 25th of June 2024, we will be hosting a 1-day workshop on
e-Campsis at the PAGE meeting  in Rome.

As a participant you will get free access to e-Campsis pro. You will learn
how to:

   - Import a model from various sources (Campsis, model library, NONMEM)
   - Set up a trial design
   - Bootstrap covariates from an external source (e.g. NHANES)
   - Simulate specific individuals, a population or a clinical trial with
   uncertainty
   - Explore what-if scenarios thanks to the built-in scenario creator
   - Stratify and visualize the results with customizable plots
   - Post-process the results, derive useful metrics and summary statistics
   and generate HTML tables in a few clicks
   - Create forest plots in an intuitive manner to assess the impact of
   covariates
   - Make a sensitivity analysis effortlessly and understand the
   limitations of your model

You will also learn how to reproduce the simulations offline in R thanks to
the open-source package campsis.

The following registration fee applies for this 1-day workshop:

Industry:   € 300 excl. VAT

Academic:   € 150 excl. VAT

Student:€ 100 excl. VAT

The fee includes the workshop material, lunch and coffee breaks as well as
temporary access to e-Campsis pro for 2 months. On top of it you will get a
50% discount on the annual subscription fee.

This course only requires limited knowledge of R, since all hands-on
exercises will be done in the web application. You should bring your own
laptop.

Please visit www.campsis.org, page "Workshop", for more information and
registration form. You can also send an e-mail to camp...@calvagone.com.

We are looking forward to seeing you in Rome! Meanwhile, please go ahead
and try e-Campsis free! https://calvagone.github.io/ecampsis.html


Emilie, and Calvagone Team

[NMusers] Release of a new version of e-Campsis

[Emilie Henin]

Dear all,

We are happy to announce the release of a new version of e-Campsis, the
free PK/PD simulator available at *http://e-campsis.com
*.

Motivated by your positive feedback after the first release a few weeks
ago, we focused our efforts and implemented some powerful new features.

It is now super easy to keep track of parameter names when editing your
model code. With a click of a button parameter names will be extracted from
your code and shown in a table where you can enter the values.

We also improved the way to enter observation times: just write a vector of
time points and enable the ‘time-after-dose’ checkbox. Your time points
will be repeated after each dosing event.

The best comes last! We have implemented a super easy way how you can
explore the impact of changes to parameter values. Want to see how a slower
absorption rate affects your PK profile? Or a faster elimination? Or both?
With a couple of clicks you can set up scenarios and compare them visually.

Check out this video *https://youtu.be/uypETm6aoNc
**c  *for a
brief introduction to these new features.



We are working without rest on a pro-version of e-Campsis which will
include many additional features such as, import and automatic translation
of NONMEM code, post-processing of simulations to calculate NCA parameters
and summarize them in a table, easy saving and loading of simulation
projects and much more.

We plan to have a beta version ready in Q4 this year.

Please stay tuned and meanwhile enjoy e-Campsis free!

*Calvagone Team*

[NMusers] Introduction to Campsis, an open-source platform to set-up and run PK-PD simulations, June 28th, Ljubljana

[Emilie Henin]

Satellite meeting at PAGE 2022: Introduction to Campsis, an open-source
platform to set-up and run PK-PD simulations

Dear colleagues,
Calvagone is running a 1-day hands-on course on Campsis on Tuesday 28th of
June 2022.
This course is an opportunity to discover Campsis (www.campsis.org), a new,
intuitive, and open-source platform to set-up and run your model-based
PK-PD simulations with ease.

The course will focus, through hands-on exercises, on the basic use of
Campsis: from the execution of PK and PK-PD simulations (typical
profile/specific individuals/population), to clinical trial simulations.

For more information and registration, please visit our website:
https://calvagone.github.io/workshop_page.html

Or contact us by e-mail: cont...@calvagone.com

Looking forward to seeing you in Ljubljana in June! :)

[NMusers] 4th European Training course on PK-PD of Protein Therapeutics, Lyon, November 20-22 2019: Registration are open!

[Emilie Henin]

Dear Colleagues,

Registrations are now open!



*The 4th European Training Course on*
*Pharmacokinetics and Pharmacodynamics of Protein Therapeutics – Principles
and Pharmacometric Approaches *
will be held in Lyon, France, on November 20-22 2019.

The 3-day course is a shortened version of the course which has been given
for the last nine years by Prof Bernd Meibohm & Johan Gabrielsson in the
United States, and it is organized in Europe under the aegis of AP2POP.



During this course, you will be introduced to basic principles in the
pharmacokinetic and pharmacodynamic evaluation of novel therapeutic
proteins and hands-on exercises in the PK/PD evaluation of these compounds.
Topics include target-mediated drug disposition, tissue and tumor
penetration, first-in-human dose selection, immunogenicity, clinical
pharmacology challenges, biosimilars, and drug-drug interactions. The
target audience comprises pharmaceutical scientists from industry, academia
and regulatory agencies with basic knowledge in PK and PKPD that would like
to receive a comprehensive overview or refresher on the PK and PKPD of this
class of compounds. Hands-on exercises will be performed individually and
in small groups using simple software tools (no prior experience required).



*Attendance and registration:*

The attendance will be strictly limited to 35 participants, allowing nice
interactions. As well, a limited number of spots at a reduced fee have been
reserved for academics and students.



For more detailed information on the course program, as well as on the
registration process, please visit:

*Information:* http://www.ap2pop.org/formations



*Registration form:*
http://www.ap2pop.org/assets/PDF/Plaquette-formation-AP2POP-2019-PKPDofPT.pdf



*Contact:* cont...@ap2pop.org




Looking forward to seeing you in Lyon !


*The Course Directors*
Bernd Meibohm, University of Tennessee & Johan Gabrielsson, Swedish
University of Agricultural Sciences



*The Local Organizers*

Emilie Hénin, Philippe Pierrillas and Christian Laveille, AP2POP & Calvagone




Emilie, on behalf of the organizing committee







Emilie HENIN - DEVESSIERE, PhD HDR

Consultant in Pharmacometrics





AP2POP, Association pour la Promotion de la Pharmacocinétique de Population

Secretary of AP2POP

[NMusers] 4th European Training Course on PK-PD of Protein Therapeutics, Lyon, November 20-22 2019: first announcement!

[Emilie Henin]

Dear colleagues,



After a very successful 3rd European course, we are pleased to announce
that the 4th European course on Pharmacokinetics and Pharmacodynamic
principles of Protein Therapeutics, directed by Pr Bernd Meibohm and Pr
Johan Gabrielsson, will be held in Lyon (France), *November 20 – 22 2019*.



The course fees, including course material, lunches, coffee and tea breaks,
will be 1800 €. A limited number of seats at a reduced fare of 600€ will be
available for students and academics.



For more information, please contact us : cont...@ap2pop.org



Emilie,

on behalf of the organizing committee





*Emilie HENIN, PhD HDR*

Consultant in Pharmacometrics



AP2POP, Association pour la Promotion de la Pharmacocinétique de Population

Secretary of AP2POP

[NMusers] 3rd European Training Course on PK-PD of Protein Therapeutics, Lyon, November 28-30 2018

[Emilie Henin]

Dear Colleagues,

We are happy to announce the



*3rd European Training Course on*
*Pharmacokinetics and Pharmacodynamics of Protein Therapeutics – Principles
and Pharmacometric Approaches *
that will be held in Lyon, France on November 28-30, 2018.

The 3-day course is a shortened version of the course which has been given
for the last eight years  by Prof Bernd Meibohm & Johan Gabrielsson in the
United States, and it is organized in Europe for the third time under the
aegis of AP2POP association.



During this course, you will be introduced to basic principles in the
pharmacokinetic and pharmacodynamic evaluation of novel therapeutic
proteins and hands-on exercises in the PK/PD evaluation of these compounds.
Topics include target-mediated drug disposition, tissue and tumor
penetration, first-in-human dose selection, immunogenicity, clinical
pharmacology challenges, biosimilars, and drug-drug interactions. The
target audience comprises pharmaceutical scientists from industry, academia
and regulatory agencies with basic knowledge in PK and PKPD that would like
to receive a comprehensive overview or refresher on the PK and PKPD of this
class of compounds. Hands-on exercises will be performed individually and
in small groups using simple software tools (no prior experience required).



*Attendance and registration:*

The attendance will be strictly limited to 35 participants, allowing nice
interactions. As well, a limited number of spots have been reserved for
academia and trainees for one third of the price.

For more detailed information on the preliminary course program, as well as
on the registration process, please visit:


*Information: **http://www.ap2pop.org/formations
<http://www.ap2pop.org/formations>*



*Registration form:*
http://www.ap2pop.org/assets/PDF/Plaquette-formation-AP2POP-2018-PKPDofPT.pdf




Looking forward to seeing you in Lyon!


*The Course Directors*
Bernd Meibohm, University of Tennessee & Johan Gabrielsson, Swedish
University of Agricultural Sciences



*The Local Organizers*

Emilie Hénin and Christian Laveille, Calvagone & AP2POP









*Emilie HENIN, PhD HDR*

Consultant in Pharmacometrics



AP2POP, Association pour la Promotion de la Pharmacocinétique de Population

Secretary of AP2POP

[NMusers] 3rd European Training Course on PK-PD of Protein Therapeutics, Lyon, November 28-30 2018: first announcement!

[Emilie Henin]

Dear colleagues,


The 3rd European course on Pharmacokinetics and Pharmacodynamic principles
of Protein Therapeutics, directed by Pr Bernd Meibohm and Pr Johan
Gabrielsson, will be held in Lyon (France), *November 28 – 30 2018*.



The course fees, including course material, lunches, coffee and tea breaks,
will be 1800 €. A limited number of seats at a reduced fare of 600€ will be
available for students and academics.


For more information, please contact us : cont...@ap2pop.org



Emilie,

on behalf of the organizing committee

[NMusers] 2nd European Training Course on PK-PD of Protein Therapeutics, Darmstadt, August 29-31 2017: Late-bird registration!

[Emilie Henin]

Dear Colleagues,



Last chance to register to the :

*2nd European Training Course on Pharmacokinetics and Pharmacodynamics of
Protein Therapeutics – Principles and Pharmacometric Approaches*



Directed by Bernd Meibohm (University of Tennessee) and Johan Gabrielsson
(Swedish University of Agricultural Sciences )

To be held in Darmstadt, Germany on *August 29-31, 2017*.



Due to the high interest in our training course, we have added a few
additional seats to accommodate the demand.

Thanks to the sponsoring of Merck,  few seats for academics and students
are still available at a reduced fee (500€ instead of 1400€, including fees
for course, lunches and coffee breaks)





For more information, please contact us at cont...@ap2pop.org or click on
the links below



*Information:* http://www.ap2pop.org/formations

*Registration form:*
http://www.ap2pop.org/assets/PDF/Plaquette-formation-AP2POP-2017-PKPDofPT.pdf






On behalf of the organising committee,





*Emilie HENIN, PhD HDR*

Consultant in Pharmacometrics



AP2POP, Association pour la Promotion de la Pharmacocinétique de Population

Secretary of AP2POP

2017-08-01 15:11 GMT+02:00 Emilie Henin <emilie.he...@gmail.com>:

> Dear Colleagues,
>
>
>
> Few seats are still available for the
>
> *2nd European Training Course on Pharmacokinetics and Pharmacodynamics of
> Protein Therapeutics – Principles and Pharmacometric Approaches*
>
>
>
> Directed by Bernd Meibohm (University of Tennessee) and Johan Gabrielsson
> (Swedish University of Agricultural Sciences )
>
> To be held in Darmstadt, Germany on *August 29-31, 2017*.
>
>
>
> Thanks to the sponsoring of Merck,  seats for academics and students are
> available at a reduced fee (500€ instead of 1400€, including fees for
> course, lunches and coffee breaks)
>
>
>
>
>
> For more information, please contact us at cont...@ap2pop.org or click on
> the links below
>
>
>
> *Information:* *http://www.ap2pop.org/formations
> <http://www.ap2pop.org/formations>*
>
> *Registration form:* http://www.ap2pop.org/assets/PDF/Plaquette-
> formation-AP2POP-2017-PKPDofPT.pdf
>
>
>
>
>
> On behalf of the organising committee,
>
>
>
>
>
> *Emilie HENIN, PhD HDR*
>
> Consultant in Pharmacometrics
>
>
>
> AP2POP, Association pour la Promotion de la Pharmacocinétique de Population
>
> Secretary of AP2POP
>
>
>
> 2017-05-11 17:56 GMT+02:00 Emilie Henin <emilie.he...@gmail.com>:
>
>> Dear Colleagues,
>>
>> We are happy to announce the
>>
>>
>>
>> *2nd European Training Course on*
>> *Pharmacokinetics and Pharmacodynamics of Protein Therapeutics –
>> Principles and Pharmacometric Approaches *
>> that will be held in Darmstadt, Germany on August 29-31, 2017.
>>
>> The 3-day course is a shortened version of the course which has been
>> given for the last seven years  by Prof Bernd Meibohm & Johan Gabrielsson
>> in the United States, and it is organized in EUROPE under the aegis of
>> AP2POP and with the sponsoring of Merck.
>>
>>
>>
>> During this course, you will be introduced to basic principles in the
>> pharmacokinetic and pharmacodynamic evaluation of novel therapeutic
>> proteins and hands-on exercises in the PK/PD evaluation of these compounds.
>> Topics include target-mediated drug disposition, tissue and tumor
>> penetration, first-in-human dose selection, immunogenicity, clinical
>> pharmacology challenges, biosimilars, and drug-drug interactions. The
>> target audience comprises pharmaceutical scientists from industry, academia
>> and regulatory agencies with basic knowledge in PK and PKPD that would like
>> to receive a comprehensive overview or refresher on the PK and PKPD of this
>> class of compounds. Hands-on exercises will be performed individually and
>> in small groups using simple software tools (no prior experience required).
>>
>>
>>
>> *Attendance and registration:*
>>
>> The attendance will be strictly limited to 35 participants, allowing nice
>> interactions. As well, a limited number of spots have been reserved for
>> academia and trainees for one third of the price thanks to Merck
>> sponsoring.
>>
>>
>>
>> For more detailed information on the preliminary course program, as well
>> as on the registration process, please visit:
>>
>> *Information:*   http://www.ap2pop.org/formations
>> <http://www.ap2pop.org/fr/Formations>
>>
>> *Registration form:* http://www.ap2pop.org/assets/P
>> DF/Plaquette-formation-AP2POP-2017-PKPDofPT.pdf
>>
>>
>>
>>
>> Looking forward to seeing you in Darmstadt next summer !
>>
>>
>> *The Course Directors*
>> Bernd Meibohm, University of Tennessee & Johan Gabrielsson, Swedish
>> University of Agricultural Sciences
>>
>>
>>
>> *The Local Organizers*
>>
>> Pascal Girard and Maike Puetter, Merck; Christian Laveille, Calvagone
>>
>
>

[NMusers] 2nd European Training Course on PK-PD of Protein Therapeutics, Darmstadt, August 29-31 2017: few seats available!

[Emilie Henin]

Dear Colleagues,



Few seats are still available for the

*2nd European Training Course on Pharmacokinetics and Pharmacodynamics of
Protein Therapeutics – Principles and Pharmacometric Approaches*



Directed by Bernd Meibohm (University of Tennessee) and Johan Gabrielsson
(Swedish University of Agricultural Sciences )

To be held in Darmstadt, Germany on *August 29-31, 2017*.



Thanks to the sponsoring of Merck,  seats for academics and students are
available at a reduced fee (500€ instead of 1400€, including fees for
course, lunches and coffee breaks)





For more information, please contact us at cont...@ap2pop.org or click on
the links below



*Information:* *http://www.ap2pop.org/formations
<http://www.ap2pop.org/formations>*

*Registration form:*
http://www.ap2pop.org/assets/PDF/Plaquette-formation-AP2POP-2017-PKPDofPT.pdf






On behalf of the organising committee,





*Emilie HENIN, PhD HDR*

Consultant in Pharmacometrics



AP2POP, Association pour la Promotion de la Pharmacocinétique de Population

Secretary of AP2POP



2017-05-11 17:56 GMT+02:00 Emilie Henin <emilie.he...@gmail.com>:

> Dear Colleagues,
>
> We are happy to announce the
>
>
>
> *2nd European Training Course on*
> *Pharmacokinetics and Pharmacodynamics of Protein Therapeutics –
> Principles and Pharmacometric Approaches *
> that will be held in Darmstadt, Germany on August 29-31, 2017.
>
> The 3-day course is a shortened version of the course which has been given
> for the last seven years  by Prof Bernd Meibohm & Johan Gabrielsson in the
> United States, and it is organized in EUROPE under the aegis of AP2POP and
> with the sponsoring of Merck.
>
>
>
> During this course, you will be introduced to basic principles in the
> pharmacokinetic and pharmacodynamic evaluation of novel therapeutic
> proteins and hands-on exercises in the PK/PD evaluation of these compounds.
> Topics include target-mediated drug disposition, tissue and tumor
> penetration, first-in-human dose selection, immunogenicity, clinical
> pharmacology challenges, biosimilars, and drug-drug interactions. The
> target audience comprises pharmaceutical scientists from industry, academia
> and regulatory agencies with basic knowledge in PK and PKPD that would like
> to receive a comprehensive overview or refresher on the PK and PKPD of this
> class of compounds. Hands-on exercises will be performed individually and
> in small groups using simple software tools (no prior experience required).
>
>
>
> *Attendance and registration:*
>
> The attendance will be strictly limited to 35 participants, allowing nice
> interactions. As well, a limited number of spots have been reserved for
> academia and trainees for one third of the price thanks to Merck
> sponsoring.
>
>
>
> For more detailed information on the preliminary course program, as well
> as on the registration process, please visit:
>
> *Information:*   http://www.ap2pop.org/formations
> <http://www.ap2pop.org/fr/Formations>
>
> *Registration form:* http://www.ap2pop.org/assets/PDF/Plaquette-formation-
> AP2POP-2017-PKPDofPT.pdf
>
>
>
>
> Looking forward to seeing you in Darmstadt next summer !
>
>
> *The Course Directors*
> Bernd Meibohm, University of Tennessee & Johan Gabrielsson, Swedish
> University of Agricultural Sciences
>
>
>
> *The Local Organizers*
>
> Pascal Girard and Maike Puetter, Merck; Christian Laveille, Calvagone
>

[NMusers] Re: 2nd European Training Course on PK-PD of Protein Therapeutics, Darmstadt, August 29-31 2017: registration opening!

[Emilie Henin]

Dear Colleagues,


Following the previous announcement, please ignore previous link to the
website and use this updated one : http://www.ap2pop.org/formations

The link to the flyer is:
http://www.ap2pop.org/assets/PDF/Plaquette-formation-AP2POP-2017-PKPDofPT.pdf



Emilie,

On behalf of the organizing committee

Secretary of AP2POP

2017-05-11 17:56 GMT+02:00 Emilie Henin <emilie.he...@gmail.com>:

> Dear Colleagues,
>
> We are happy to announce the
>
>
>
> *2nd European Training Course on*
> *Pharmacokinetics and Pharmacodynamics of Protein Therapeutics –
> Principles and Pharmacometric Approaches *
> that will be held in Darmstadt, Germany on August 29-31, 2017.
>
> The 3-day course is a shortened version of the course which has been given
> for the last seven years  by Prof Bernd Meibohm & Johan Gabrielsson in the
> United States, and it is organized in EUROPE under the aegis of AP2POP and
> with the sponsoring of Merck.
>
>
>
> During this course, you will be introduced to basic principles in the
> pharmacokinetic and pharmacodynamic evaluation of novel therapeutic
> proteins and hands-on exercises in the PK/PD evaluation of these compounds.
> Topics include target-mediated drug disposition, tissue and tumor
> penetration, first-in-human dose selection, immunogenicity, clinical
> pharmacology challenges, biosimilars, and drug-drug interactions. The
> target audience comprises pharmaceutical scientists from industry, academia
> and regulatory agencies with basic knowledge in PK and PKPD that would like
> to receive a comprehensive overview or refresher on the PK and PKPD of this
> class of compounds. Hands-on exercises will be performed individually and
> in small groups using simple software tools (no prior experience required).
>
>
>
> *Attendance and registration:*
>
> The attendance will be strictly limited to 35 participants, allowing nice
> interactions. As well, a limited number of spots have been reserved for
> academia and trainees for one third of the price thanks to Merck
> sponsoring.
>
>
>
> For more detailed information on the preliminary course program, as well
> as on the registration process, please visit:
>
> *Information:*   http://www.ap2pop.org/formations
> <http://www.ap2pop.org/fr/Formations>
>
> *Registration form:* http://www.ap2pop.org/assets/PDF/Plaquette-formation-
> AP2POP-2017-PKPDofPT.pdf
>
>
>
>
> Looking forward to seeing you in Darmstadt next summer !
>
>
> *The Course Directors*
> Bernd Meibohm, University of Tennessee & Johan Gabrielsson, Swedish
> University of Agricultural Sciences
>
>
>
> *The Local Organizers*
>
> Pascal Girard and Maike Puetter, Merck; Christian Laveille, Calvagone
>

[NMusers] 2nd European Training Course on PK-PD of Protein Therapeutics, Darmstadt, August 29-31 2017: registration opening!

[Emilie Henin]

Dear Colleagues,

We are happy to announce the



*2nd European Training Course on*
*Pharmacokinetics and Pharmacodynamics of Protein Therapeutics – Principles
and Pharmacometric Approaches *
that will be held in Darmstadt, Germany on August 29-31, 2017.

The 3-day course is a shortened version of the course which has been given
for the last seven years  by Prof Bernd Meibohm & Johan Gabrielsson in the
United States, and it is organized in EUROPE under the aegis of AP2POP and
with the sponsoring of Merck.



During this course, you will be introduced to basic principles in the
pharmacokinetic and pharmacodynamic evaluation of novel therapeutic
proteins and hands-on exercises in the PK/PD evaluation of these compounds.
Topics include target-mediated drug disposition, tissue and tumor
penetration, first-in-human dose selection, immunogenicity, clinical
pharmacology challenges, biosimilars, and drug-drug interactions. The
target audience comprises pharmaceutical scientists from industry, academia
and regulatory agencies with basic knowledge in PK and PKPD that would like
to receive a comprehensive overview or refresher on the PK and PKPD of this
class of compounds. Hands-on exercises will be performed individually and
in small groups using simple software tools (no prior experience required).



*Attendance and registration:*

The attendance will be strictly limited to 35 participants, allowing nice
interactions. As well, a limited number of spots have been reserved for
academia and trainees for one third of the price thanks to Merck
sponsoring.



For more detailed information on the preliminary course program, as well as
on the registration process, please visit:

*Information:*   http://www.ap2pop.org/formations


*Registration form:*
http://www.ap2pop.org/assets/PDF/Plaquette-formation-AP2POP-2017-PKPDofPT.pdf





Looking forward to seeing you in Darmstadt next summer !


*The Course Directors*
Bernd Meibohm, University of Tennessee & Johan Gabrielsson, Swedish
University of Agricultural Sciences



*The Local Organizers*

Pascal Girard and Maike Puetter, Merck; Christian Laveille, Calvagone